Yang W, Lu L, Cheng J, He X
Heliyon. 2025; 11(1):e41258.
PMID: 39839511
PMC: 11748725.
DOI: 10.1016/j.heliyon.2024.e41258.
Martin J, Borges A, Beck D
Eur J Appl Physiol. 2015; 115(9):2019-29.
PMID: 25981709
DOI: 10.1007/s00421-015-3187-8.
Bozorgi A, Mehrabi Nasab E, Sardari A, Nejatian M, Nasirpour S, Sadeghi S
J Tehran Heart Cent. 2015; 9(1):33-7.
PMID: 25561968
PMC: 4277789.
Braverman D, Braitman L, Figueredo V, Figeuredo V
Clin Cardiol. 2012; 36(2):82-7.
PMID: 23109041
PMC: 6649409.
DOI: 10.1002/clc.22073.
Jenkins N, Martin J, Laughlin M, Padilla J
Curr Cardiovasc Risk Rep. 2012; 6(4):331-346.
PMID: 22844545
PMC: 3404842.
DOI: 10.1007/s12170-012-0241-5.
Passive tobacco exposure may impair symptomatic improvement in patients with chronic angina undergoing enhanced external counterpulsation.
Efstratiadis S, Kennard E, Kelsey S, Michaels A
BMC Cardiovasc Disord. 2008; 8:23.
PMID: 18798998
PMC: 2553398.
DOI: 10.1186/1471-2261-8-23.
Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the International Enhanced External Counterpulsation Patient Registry.
Loh P, Cleland J, Louis A, Kennard E, Cook J, Caplin J
Clin Cardiol. 2008; 31(4):159-64.
PMID: 18404725
PMC: 6652881.
DOI: 10.1002/clc.20117.
Portable enhanced external counterpulsation for acute coronary syndrome and cardiogenic shock: a pilot study.
Cohen J, Grossman W, Michaels A
Clin Cardiol. 2007; 30(5):223-8.
PMID: 17492675
PMC: 6653134.
DOI: 10.1002/clc.20074.
Two-year outcomes in patients with mild refractory angina treated with enhanced external counterpulsation.
Lawson W, Hui J, Kennard E, Kelsey S, Michaels A, Soran O
Clin Cardiol. 2006; 29(2):69-73.
PMID: 16506642
PMC: 6654129.
DOI: 10.1002/clc.4960290207.
Exercise capability and myocardial perfusion in chronic angina patients treated with enhanced external counterpulsation.
Tartaglia J, Stenerson Jr J, Charney R, Ramasamy S, Fleishman B, Gerardi P
Clin Cardiol. 2003; 26(6):287-90.
PMID: 12839048
PMC: 6654506.
DOI: 10.1002/clc.4950260610.
The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results.
Barsness G, Feldman A, Holmes Jr D, Holubkov R, Kelsey S, Kennard E
Clin Cardiol. 2001; 24(6):435-42.
PMID: 11403504
PMC: 6654842.
DOI: 10.1002/clc.4960240604.
Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study.
Lawson W, Hui J, Cohn P
Clin Cardiol. 2000; 23(4):254-8.
PMID: 10763072
PMC: 6655097.
DOI: 10.1002/clc.4960230406.
Therapeutic angiogenesis.
Henry T
BMJ. 1999; 318(7197):1536-9.
PMID: 10356013
PMC: 1115905.
DOI: 10.1136/bmj.318.7197.1536.
Enhanced external counterpulsation in the management of patients with cardiovascular disease.
Soran O, Crawford L, SCHNEIDER V, Feldman A
Clin Cardiol. 1999; 22(3):173-8.
PMID: 10084058
PMC: 6655819.
DOI: 10.1002/clc.4960220304.
Prior revascularization increases the effectiveness of enhanced external counterpulsation.
Lawson W, Hui J, Guo T, Burger L, Cohn P
Clin Cardiol. 1998; 21(11):841-4.
PMID: 9825198
PMC: 6655596.
DOI: 10.1002/clc.4960211111.
Maximizing the hemodynamic benefit of enhanced external counterpulsation.
Suresh K, Simandl S, Lawson W, Hui J, Lillis O, Burger L
Clin Cardiol. 1998; 21(9):649-53.
PMID: 9755381
PMC: 6655932.
DOI: 10.1002/clc.4960210908.
Advertising of therapies for cardiovascular patients.
Conti C
Clin Cardiol. 1997; 20(1):1.
PMID: 8994729
PMC: 6655970.
DOI: 10.1002/clc.4960200102.
